CHA2DS2-VASc score and B-type natriuretic peptide in predicting stroke, transient ischemic attack,thromboembolism and death in at-risk patients without atrial fibrillation-the STOP-HF experience
25 May 2019 (08:30 - 17:30)
Organised by:
Abstract
About the speaker
Mayo University Hospital Castlebar, Castlebar (Ireland)
13 More presentations in this session
Access the full session
The Event
Heart Failure 2019
25 May 2019
08:30 CET
You may be interested in
Webinar
24 November 2021
Congress Presentation
Congress Presentation
1 September 2025
